EPIOXA CROSS-LINKING
NDC 25357-024, riboflavin 5-phosphate ophthalmic, kit, from Glaukos Corporation.
- Product NDC
- 25357-024
- Status
- Listed
- Labeler
- Glaukos Corporation
- Dosage form
- KIT
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219910
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25357-024 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25357-024-01 | 25357002401 | 1 KIT in 1 CARTON (25357-024-01) * 1 SYRINGE, GLASS in 1 POUCH (25357-026-01) / 2 mL in 1 SYRINGE, GLASS * 1 SYRINGE, GLASS in 1 POUCH (25357-027-01) / 2 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/13cefc46-337c-41a3-b113-106bfe553bbbMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25357-024
Use it
Look up 25357-024 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25357-024 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25357-024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.